Pharma Marketing Network

NOVEMBER 15, 2024

2 Why PPC Matters in Pharma Marketing 3 Understanding Keywords and Search Intent 4 Creating High-Impact Ad Copy 5 Setting a Realistic Budget 6 Compliance and Regulatory Considerations 7 Tracking and Measuring ROI 8 Optimizing PPC Campaigns for Better Performance 9 Using PPC to Promote Branded Drugs 10 Staying Ahead of PPC Trends 1.

FDA 52

FDA 52

Pharma Marketing Network

MAY 29, 2025

Unlike classic keyword-based search, these models return contextualized responses or even direct answers without requiring a user to click a link. While these platforms aren’t pharma-specific, they do allow you to optimize content structure and keyword coverage for better AI compatibility. Tools like Parse.ly

52

52

The Nontraditional Pharmacist

JULY 1, 2025

And then paramount, obviously, is patient safety. And you need to make sure that safety is kept in top of mind. Really try to look at the roles that are out there, job descriptions and look for keywords that repeat across these and maybe try to optimize your resume or your LinkedIn profile to include some of these key words.

FDA 52

FDA Hospitals Packaging Documentation 52

Pharma Marketing Network

DECEMBER 13, 2024

Highlight unique selling points (USPs) like safety profiles, ease of use, or long-term outcomes. SEO keywords like “best cholesterol drug” or “targeted cancer therapy” improve visibility. Real-Time Feedback: Use platforms like Veeva CRM to gauge the effectiveness of your campaigns.

Dosage 52

Dosage 52

Pharma Marketing Network

OCTOBER 1, 2024

One of the primary objectives of pharma marketing is to communicate the benefits and safety profiles of medications to healthcare providers and patients. By optimizing content for relevant keywords, pharma companies can attract organic traffic from individuals seeking information about medical conditions and treatments.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies FDA 52

Roots Analysis

NOVEMBER 3, 2023

As a starting point, the information on terminated, suspended and withdrawn trials was collated from clinicaltrials.gov and PubMed using relevant search keywords. By identifying and addressing the specific issues that have led to drug failures, developers are working to improve the efficacy and safety of NAMPT inhibitors.

FDA 40

FDA 40